GL1X · GenesisL1 explorer

MolNFT v1 · #104986 · protein

Structure and specificity of L-D-transpeptidase from mycobacterium tuberculosis and antibiotic resistance: calcium binding promotes dimer formation

4QR7 · L,D-transpeptidase ldtb: “Structure and specificity of L-D-transpeptidase from mycobacterium tuberculosis and antibiotic resistance…”. X-ray diffraction, 2 ligands (MLD, DWZ), 2 pockets (best druggability 0.46). MolNFT v1 #104986 on…

PDB
4QR7
Type
protein
Length
349 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
L,D-transpeptidase ldtb
UniProt
I6Y9J2
Ligands
MLD, DWZ
Pockets
2 · best druggability 0.46

Structure

x-ray diffraction · 1 distinct chain · 8% helix, 42% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AL,D-transpeptidase ldtbprotein3498% helix, 42% strandI6Y9J2

Ligands and binding sites

  • MLD · Glcnac(beta1-4)-murnac(1,6-anhydro)-L-ala-gamma-D-glu-meso-A2PM-D-ala · ligand · chains A
  • DWZ · (2S,3R,4S)-4-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-2-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1790.460.8220empty
21240.430.7622DWZ

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 4QR7 · Structure and specificity of L-D-Transpeptidase from Mycobacterium tuberculosis and… · the same entry in another collection · chain A against A, TM-score 1.00
  • I6Y9J2 · AlphaFold monomer V2.0 prediction for L,D-transpeptidase 2 (I6Y9J2) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.